Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer.

Possible role of p53/Mieap-regulated mitochondrial quality control as a tumor suppressor in human breast cancer.
复制标题

DOI:
10.1111/cas.13824
复制
发表时间:
2018-12
期刊:
影响因子:
5.7
通讯作者:
Yoshida K
Yoshida K
中科院分区:
医学2区
文献类型:
--
作者:
Gaowa S;Futamura M;Tsuneki M;Kamino H;Tajima JY;Mori R;Arakawa H;Yoshida K

文献摘要

参考文献

被引文献

相似文献

由p53靶基因编码的线粒体进食蛋白(Mieap)在线粒体质量控制(MQC)中起着重要作用。据报道,Mieap在结直肠癌的肿瘤抑制中具有关键作用。在这里,我们研究了它作为乳腺癌肿瘤抑制因子的作用。乳腺癌细胞中外源性Mieap的强制表达诱导了caspase依赖性凋亡,并激活了caspase-3/7和caspase-9。免疫组化显示24/75(32%)例浸润性导管癌(IDC)、15/27(55.6%)例导管原位癌(DCIS)和16/18(88.9%)例纤维腺瘤(FA)的胞浆中存在内源性Mieap(IDC vs DCIS; P = 0.0389,DCIS vs FA; P = 0.0234,IDC vs FA; P <0.0001)。在IDC中,Mieap启动子在6/46(13%)例中甲基化,而p53在6/46(13%)例中突变。因此,p53/Mieap调节的MQC途径在12/46例IDC中失活(26.1%)。有趣的是,所有来自12名Mieap启动子甲基化或p53突变患者的肿瘤在病理学上表现出更具侵袭性和恶性的乳腺癌表型。p53/Mieap调节的MQC通路受损导致无病生存期(DFS)显著缩短(P = 0.021),尽管p53状态在DFS中比Mieap启动子甲基化更具预后性。这些结果表明,p53/Mieap调节的MQC在乳腺癌的肿瘤抑制中具有关键作用,可能部分通过线粒体凋亡途径。
Mitochondria‐eating protein (Mieap), encoded by a p53‐target gene, plays an important role in mitochondrial quality control (MQC). Mieap has been reported to have a critical role in tumor suppression in colorectal cancer. Here, we investigated its role as a tumor suppressor in breast cancer. The enforced expression of exogenous Mieap in breast cancer cells induced caspase‐dependent apoptosis, with activation of both caspase‐3/7 and caspase‐9. Immunohistochemistry revealed endogenous Mieap in the cytoplasm in 24/75 (32%) invasive ductal carcinomas (IDC), 15/27 (55.6%) cases of ductal carcinoma in situ (DCIS) and 16/18 (88.9%) fibroadenomas (FA) (IDC vs DCIS; P = 0.0389, DCIS vs FA; P = 0.0234, IDC vs FA; P < 0.0001). In IDC, the Mieap promoter was methylated in 6/46 (13%) cases, whereas p53 was mutated in 6/46 (13%) cases. Therefore, the p53/Mieap‐regulated MQC pathway was inactivated in 12/46 IDC (26.1%). Interestingly, all tumors derived from the 12 patients with Mieap promoter methylation or p53 mutations pathologically exhibited more aggressive and malignant breast cancer phenotypes. Impairment of p53/Mieap‐regulated MQC pathway resulted in significantly shorter disease‐free survival (DFS) (P = 0.021), although p53 status is more prognostic in DFS than Mieap promoter methylation. These results indicate that p53/Mieap‐regulated MQC has a critical role in tumor suppression in breast cancer, possibly in part through mitochondrial apoptotic pathway.
DOI: 10.1038/oncsis.2015.43
发表时间: 2016-01-04
期刊: Oncogenesis
影响因子: 6.2
作者:
Kamino H;Nakamura Y;Tsuneki M;Sano H;Miyamoto Y;Kitamura N;Futamura M;Kanai Y;Taniguchi H;Shida D;Kanemitsu Y;Moriya Y;Yoshida K;Arakawa H
通讯作者: Arakawa H
DOI: 10.1038/srep02246
发表时间: 2013
期刊: SCIENTIFIC REPORTS
影响因子: 4.6
作者:
Yang, P.;Du, C. W.;Kwan, M.;Liang, S. X.;Zhang, G. J.
通讯作者: Zhang, G. J.
DOI: 10.1016/0092-8674(93)90500-p
发表时间: 1993-11-19
期刊: CELL
影响因子: 64.5
作者:
ELDEIRY, WS;TOKINO, T;VOGELSTEIN, B
通讯作者: VOGELSTEIN, B
DOI: 10.1038/35003506
发表时间: 2000-03-02
期刊: NATURE
影响因子: 64.8
作者:
Tanaka, H;Arakawa, H;Nakamura, Y
通讯作者: Nakamura, Y
线粒体内可能存在溶酶体样细胞器及其在线粒体质量控制中的作用。
DOI: 10.1371/journal.pone.0016054
发表时间: 2011-01-17
期刊: PloS one
影响因子: 3.7
作者:
Miyamoto Y;Kitamura N;Nakamura Y;Futamura M;Miyamoto T;Yoshida M;Ono M;Ichinose S;Arakawa H
通讯作者: Arakawa H